Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Coinstar, Inc. (NASDAQ:CSTR)

Is Coinstar, Inc. (NASDAQ:CSTR) the right pick for your portfolio? Prominent investors are reducing their bets on the stock. The number of long hedge fund positions were trimmed by 1 in recent months.

In today’s marketplace, there are many methods shareholders can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite fund managers can outclass the S&P 500 by a superb amount (see just how much).

Coinstar, Inc. (NASDAQ:CSTR)

Equally as integral, bullish insider trading sentiment is another way to parse down the financial markets. As the old adage goes: there are a variety of reasons for an upper level exec to downsize shares of his or her company, but only one, very clear reason why they would buy. Plenty of empirical studies have demonstrated the useful potential of this tactic if “monkeys” understand what to do (learn more here).

With these “truths” under our belt, we’re going to take a peek at the key action surrounding Coinstar, Inc. (NASDAQ:CSTR).

What does the smart money think about Coinstar, Inc. (NASDAQ:CSTR)?

At the end of the fourth quarter, a total of 28 of the hedge funds we track held long positions in this stock, a change of -3% from one quarter earlier. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their holdings substantially.

When looking at the hedgies we track, Debra Fine’s Fine Capital Partners had the most valuable position in Coinstar, Inc. (NASDAQ:CSTR), worth close to $89 million, comprising 9% of its total 13F portfolio. On Fine Capital Partners’s heels is Marathon Partners, managed by Mario Cibelli, which held a $51 million position; 0.5% of its 13F portfolio is allocated to the stock. Some other peers that are bullish include Jim Simons’s Renaissance Technologies, Wallace Weitz’s Wallace R. Weitz & Co. and John C. Walker’s Stonerise Capital Management.

Seeing as Coinstar, Inc. (NASDAQ:CSTR) has faced falling interest from the smart money, logic holds that there lies a certain “tier” of funds that elected to cut their positions entirely at the end of the year. At the top of the heap, John Thaler’s JAT Capital Management cut the largest position of all the hedgies we key on, comprising close to $29 million in stock., and Frank LaGrange Johnson of LaGrange Capital was right behind this move, as the fund cut about $8 million worth. These bearish behaviors are important to note, as aggregate hedge fund interest fell by 1 funds at the end of the year.

How have insiders been trading Coinstar, Inc. (NASDAQ:CSTR)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past six months. Over the latest six-month time period, Coinstar, Inc. (NASDAQ:CSTR) has experienced zero unique insiders buying, and 5 insider sales (see the details of insider trades here).

With the results shown by the aforementioned time-tested strategies, retail investors must always monitor hedge fund and insider trading sentiment, and Coinstar, Inc. (NASDAQ:CSTR) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!